Jpmorgan Chase & CO Gilead Sciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,664,024 shares of GILD stock, worth $599 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,664,024

Previous 7,027,689 5.17%

Holding current value

$599 Million

Previous $482 Million 15.85%

% of portfolio

0.05%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$66.59 - $83.99 $24.2 Million - $30.5 Million	-363,665 Reduced 5.17%	6,664,024 $559 Million
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $88.1 Million - $111 Million	1,323,205 Added 24.78%	6,664,024 $559 Million
Q2 2024 Dec 26, 2024	BUY	$63.15 - $72.88 $23 Million - $26.5 Million	363,665 Added 5.46%	7,027,689 $482 Million
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $80.4 Million - $92.8 Million	-1,273,576 Reduced 19.25%	5,340,819 $366 Million
Q1 2024 Dec 26, 2024	SELL	$71.58 - $87.29 $3.55 Million - $4.33 Million	-49,629 Reduced 0.74%	6,614,395 $485 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $121 Million - $148 Million	1,694,479 Added 34.44%	6,614,395 $485 Million
Q4 2023 Dec 26, 2024	SELL	$73.27 - $83.09 $77.8 Million - $88.2 Million	-1,061,644 Reduced 15.93%	5,602,380 $454 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $39.2 Million - $44.5 Million	-535,430 Reduced 9.81%	4,919,916 $399 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $67.4 Million - $73.5 Million	911,308 Added 20.06%	5,455,346 $409 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $4.75 Million - $5.42 Million	62,515 Added 1.39%	4,544,038 $350 Million
Q1 2023 May 18, 2023	BUY	$77.31 - $88.08 $45.4 Million - $51.7 Million	586,888 Added 15.07%	4,481,523 $372 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $77.8 Million - $88.6 Million	-1,006,014 Reduced 20.53%	3,894,635 $323 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $8.06 Million - $11.6 Million	-129,381 Reduced 2.57%	4,900,649 $421 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $18 Million - $20.6 Million	-302,470 Reduced 5.67%	5,030,030 $310 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $20.7 Million - $23.3 Million	-358,190 Reduced 6.29%	5,332,500 $330 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $146 Million - $183 Million	2,524,557 Added 79.74%	5,690,690 $338 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $51.4 Million - $58.3 Million	792,003 Added 33.36%	3,166,133 $230 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $161 Million - $173 Million	2,374,130 New	2,374,130 $166 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Gilead Sciences, Inc. Transaction History